Subscribe: Market Wire - Medical and Healthcare: Facilities and Providers
Added By: Feedage Forager Feedage Grade A rated
Language: English
announces  clinical  company  health  jul  july  marketwired jul  marketwired july  marketwired  media  new  research  today 
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: Market Wire - Medical and Healthcare: Facilities and Providers

Marketwired - Hospitals, Facilities and Providers

Marketwired - Hospitals, Facilities and Providers

Last Build Date: Thu, 20 Jul 2017 13:50:28 EDT

Copyright: Copyright: (C) Marketwired

ECPO Files Issuers Company Related Action Notification with the Financial Industry Regulatory Authority requesting Name and Symbol Change

Thu, 20 Jul 2017 13:19:52 EDT

The Company Also Updated Progress on the Validation Process for its ITV-1 Patented HIV/AIDS Treatment

Wolters Kluwer Expands Simplifi 797 Functionality to Create a Turnkey USP 800 Compliance Solution Focused on Safe Management of Hazardous Drug Compounding

Thu, 20 Jul 2017 11:13:43 EDT

BELLEVUE, WA--(Marketwired - Jul 20, 2017) - Wolters Kluwer, a leading global provider of information and point of care solutions for the healthcare industry, announced today the further expansion of functionality within Simplifi 797®, creating a turnkey USP 800 solution that addresses important employee education and safety needs to ensure safe compounding of hazardous drugs. These enhancements mean facilities can now rely on a single solution to ensure staff and patient safety, maximize pharmacy operational efficiencies, and guide proper handling and storage of sterile compounded preparations.

DirectTrust Reports Steady Growth in Number of Direct Exchange Users, Addresses and Transactions during Second Quarter

Thu, 20 Jul 2017 09:30:00 EDT

Five new members join DirectTrust since April 1

MTBC Named in 2017 Ranking of the Top 15 Medical Billing Companies in the United States

Thu, 20 Jul 2017 09:15:08 EDT

SOMERSET, NJ--(Marketwired - Jul 20, 2017) - MTBC (NASDAQ: MTBC) (NASDAQ: MTBCP), a leading provider of proprietary, cloud-based healthcare IT solutions and services, today announced that it has been ranked as one of the top 15 medical billing companies in the United States, according to Becker's Hospital Review.

Vet Online Supply Launches Cannabis CBD Pet Product Line

Thu, 20 Jul 2017 09:00:00 EDT

Clinical studies prove effectiveness of cannabidiol in treating canine ailments

SANUWAVE Appoints Alat Medika Indonesia as Distributor for dermaPACE and Liaison to Clinical Trials Participation for Company's Wound Care Product(s) in Indonesia

Thu, 20 Jul 2017 09:00:00 EDT

SUWANEE, GA--(Marketwired - Jul 20, 2017) - SANUWAVE Health, Inc. (OTCQB: SNWV) is pleased to announce that the Company has appointed Alat Medika Indonesia as distributor for dermaPACE® and liaison for clinical trials participation for Company's wound care product in Indonesia. The expected revenue from this agreement will be north of $1 million over the next three years.

Lexington Biosciences Introduces Medical Advisory Board

Thu, 20 Jul 2017 08:30:00 EDT

Advisory team prepares to move HeartSentry through clinical studies

Increased Revenues, Refill Gains Identified by American Pharmacies as Top Benefits of RxCOMPASS, Powered by FDS Inc.'s myDataMart

Thu, 20 Jul 2017 08:30:00 EDT

Buying cooperative shares study results demonstrating financial gains generated by robust pharmacy business intelligence tool

Philadelphia Plastic Surgeon Named One of "America's Top Doctors" for 17th Consecutive Year

Thu, 20 Jul 2017 08:01:00 EDT

Castle Connolly has identified Louis P. Bucky, MD as a 2017 "Top Doctor" in plastic surgery

Company Announces Continued Development of its Online Presence and Ongoing Negotiations for an Extraction Joint-Venture to Satisfy CBD Oil Demand in the Northeast

Thu, 20 Jul 2017 08:00:00 EDT

NEW YORK, NY--(Marketwired - Jul 20, 2017) - HempAmericana, Inc. (OTC PINK: HMPQ) is proud to announce it is now selling CBD oil off its newly designed website It is important for the company to continue its retail sales while it develops a hemp extraction process directly under its control. The company's CEO Salvador Rosillo stated, "We are extremely excited to have retail sales as a base, while we develop our own internal extraction process. While these early sales are financially nominal and the orders are small, we will implement a SEO program that will target markets to sell our oils into in the near future."

Clinical Teams From Top Pharma Companies Are Overcoming Challenges in Planning and Implementing Adaptive Trial Design Studies

Wed, 19 Jul 2017 19:23:00 EDT

RESEARCH TRIANGLE PARK, NC--(Marketwired - July 19, 2017) - A recent study of Top 10, Top 50, and small medical device companies found that addressing regulators' concerns for late-stage studies is the most common challenge clinical development teams encounter during their adaptive trial design preparations, according to research published by business intelligence firm Cutting Edge Information.

ORHub, Inc. Executing Aggressive Expansion Strategy with Introduction of Third Service Line

Wed, 19 Jul 2017 11:54:40 EDT

NEWPORT BEACH, CA--(Marketwired - Jul 19, 2017) - Less than a week after declaring its nationwide deployment strategy, ORHub, Inc. (OTC: ORHB) today announces its entrance into the cardiac segment of health care through the launch of its Cardiac and Cardiology service line.

AAED 2017 San Diego: Dental Marketing Firm Rosemont Media to Exhibit at Interdisciplinary Summit

Wed, 19 Jul 2017 11:01:00 EDT

San Diego-based dental website design firm Rosemont Media will be exhibiting advanced marketing technology at the American Academy of Esthetic Dentistry's 2017 Interdisciplinary Summit

Growth of Social Isolation and Loneliness in Seniors Underscores Need for Technology Solutions

Wed, 19 Jul 2017 10:30:00 EDT

Whitepaper from GreatCall and Aging in Place Technology Watch discusses health risks associated with loneliness and offers solutions to mitigate risks

UPDATE - Medovex Corporation Announces First Human Cases Using Its DenerveX Device and First Revenue Events

Wed, 19 Jul 2017 09:17:59 EDT

Highly Disruptive and Patented Less Invasive Device with Faster Recovery Time than Current Surgical Treatment Options for Facet Joint Syndrome

Invictus MD Completes First Harvest & Breaks Ground on Expansion -- CFN Media

Wed, 19 Jul 2017 09:00:00 EDT

SEATTLE, WA--(Marketwired - Jul 19, 2017) - CFN Media Group ("CannabisFN"), the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article examining Invictus MD Strategies Corp.'s (TSX VENTURE: IMH) (OTC PINK: IVITF) progress in building out its presence in Canada's licensed producer marketplace, as well as its successful ancillary businesses.

American Cannabis Company, Inc. Announces It Has Secured A Second Contract With A New Client In Arkansas

Wed, 19 Jul 2017 08:30:00 EDT

DENVER, CO--(Marketwired - Jul 19, 2017) - American Cannabis Company, Inc. (OTCQB: AMMJ) ("ACC"), a full-service business-to-business consulting solutions provider and seller of ancillary products to the cannabis industry, today announced it has secured its second client in the state of Arkansas. ACC will initially provide strategic planning and pre-licensing solutions for this new client, which include operational planning activities, facility conceptual design work and state application completion. ACC expects to leverage this contract to secure additional revenues through long-term consulting agreements and potential future sales of ancillary products.

BriaCell Provides Clinical Update on its Ongoing Phase I/IIa Clinical Study of BriaVax(TM) in Advanced Breast Cancer

Wed, 19 Jul 2017 08:30:00 EDT

BERKELEY, CA and VANCOUVER, BC--(Marketwired - July 19, 2017) - BriaCell Therapeutics Corp. ("BriaCell" or the "Company") (TSX VENTURE: BCT) (OTCQB: BCTXF), an immuno-oncology focused biotechnology company, provided a clinical update regarding its US-based open-label Phase I/IIa clinical trial evaluating the safety and efficacy of BriaVaxT, a genetically engineered whole-cell vaccine derived from a human breast cancer cell line, to treat advanced breast cancer.

CFN Media Exclusive Interview with OWCP's Dr. Sharon Rozenblat

Wed, 19 Jul 2017 08:30:00 EDT

SEATTLE, WA--(Marketwired - Jul 19, 2017) - CFN Media Group, the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article and exclusive interview with Dr. Sharon Rozenblat, Advisory Board Member for OWC Pharmaceutical Research Corp. (OTCQB: OWCP). Dr. Rozenblat is largely responsible for the development of the company's active cannabinoid topical skin cream, and the interview focuses on that product and its potential in the rapidly growing multi-billion dollar psoriasis market.

Ten Healthcare Organizations Select BIO-key Fingerprint Biometric Authentication to Meet Multifactor Authentication Requirements

Wed, 19 Jul 2017 08:03:00 EDT

Organizations find fingerprint authentication faster, more convenient and more secure than alternatives such as passwords

Medovex Announces First Human Cases Using Its DenerveX Device and First Revenue Events

Wed, 19 Jul 2017 08:00:00 EDT

Highly Disruptive and Patented Less Invasive Device with Faster Recovery Time than Current Surgical Treatment Options for Facet Joint Syndrome

Emerging Issues for Pharma R&D: A Practical Approach for Pediatric Drug Programs, New Webinar Hosted by Xtalks

Wed, 19 Jul 2017 07:30:00 EDT

TORONTO, ON--(Marketwired - July 19, 2017) - In this webinar scheduled for Wednesday, August 16, 2017 at 11am EDT (4pm BST/), industry experts Dr. Barry Mangum from Paidion Research and Dr. JF Marier from Certara will discuss how pediatric considerations fit into the overall drug development program. They will also make recommendations for addressing issues from both a practical and scientific perspective. Anonymized case studies will be presented with a review of historical issues with a focus on solutions for today (i.e. licensed comparators differences in US and EU, importation issues, and endpoint selection

Medigus Expands Global Commercial Availability of MUSE Through Distribution Agreement With Izasa Hospital, S.L.U. in Spain

Wed, 19 Jul 2017 07:00:00 EDT

OMER, ISRAEL--(Marketwired - Jul 19, 2017) -  Medigus Ltd. (NASDAQ: MDGS) (TASE: MDGS), a medical device company developing minimally invasive endosurgical tools and a leader in direct visualization technology, today announced a distribution agreement in Spain with Izasa Hospital, S.L.U., a distributor of medical products in the hospital sector. The five year commercialization agreement took effect July 1, 2017; Izasa Hospital, S.L.U. will be required to purchase a minimum of EUR 1.4 million of Medigus Ultrasonic Surgical Endostapler (MUSET) equipment over the course of the agreement.

PathPartner Technology Contributes to Arthromeda's Successful Preclinical Study of Arthrosight-PS(TM) Hip Alignment Navigation System

Wed, 19 Jul 2017 03:01:00 EDT

FREMONT, CA--(Marketwired - July 19, 2017) - PathPartner Technology Inc., a technology enabler in developing intelligent systems, announces a successful cadaveric study of Arthromeda's ( innovative patient-specific hip alignment navigation product, Arthrosight-PST.

ICTV Brands, Inc. Terminates Royalty Agreement

Tue, 18 Jul 2017 16:00:00 EDT

WAYNE, PA--(Marketwired - Jul 18, 2017) - ICTV Brands, Inc. (OTCQX: ICTV), (CSE: ITV)

BRG Healthcare Professionals Publish Whitepaper Measuring Size of 340B Drug Discount Program

Tue, 18 Jul 2017 15:58:20 EDT

EMERYVILLE, CA--(Marketwired - July 18, 2017) - Global strategic advisory and expert consulting firm Berkeley Research Group announced today that Managing Director Aaron Vandervelde and Senior Managing Consultant Eleanor Blalock have published a new whitepaper, Measuring the Relative Size of the 340B Program: 2012-2017. This study was funded by the Pharmaceutical Research and Manufacturers of America.

Healthcare IT / Digital Health Sector Sets All-Time Record With $4 Billion in VC Funding in 1H 2017, $2.4 Billion in Q2 2017, Reports Mercom Capital Group

Tue, 18 Jul 2017 11:01:00 EDT

AUSTIN, TX--(Marketwired - Jul 18, 2017) - Mercom Capital Group, llc, a global communications and research firm, released its report on funding and mergers and acquisitions (M&A) activity for the Healthcare Information Technology (IT) / Digital Health sector for the second quarter (Q2) and first half (1H) of 2017. Mercom's comprehensive report covers deals of all sizes from across the globe.

Governing Approved for $150,000 Engagement Award for Project on Innovation Dissemination across State & Local Health Systems

Tue, 18 Jul 2017 09:00:00 EDT

WASHINGTON, DC--(Marketwired - July 18, 2017) - Governing has been approved for a $150,000 funding award through the Eugene Washington PCORI Engagement Awards program, an initiative of the Patient-Centered Outcomes Research Institute (PCORI). The funds will support the diffusion of innovation, promising practices and new evidence about person-centered, outcome focused approaches in state and local health systems.

Cancer as a Chronic Disease: The Past, the Present and the Future of Cancer Research

Tue, 18 Jul 2017 08:00:00 EDT

This Xtalks webinar, conducted by one of the US's foremost cancer researchers, Dr. Lee Schwartzberg, of the West Cancer Centre and Scientific Leader at George Clinical, will discuss cancer as a chronic disease and how researching cancer under this new archetype is adjusting the way in which clinical oncology trials are conducted and how cancer patients are treated

Melissa Powers Know Your Customer Initiatives for Meta Payment Systems

Tue, 18 Jul 2017 08:00:00 EDT

Seamless Data Verification and Geocoding Prevents Customer Fraud in Real-Time

Into the Great Wide Open: PTC's transformation & Global Journey to Bring Patients a First Ever Rare Disease Therapy, New Webinar Hosted by Xtalks

Tue, 18 Jul 2017 07:30:00 EDT

TORONTO, ON--(Marketwired - July 18, 2017) - The rare disease biopharmaceutical landscape continues to evolve, but despite the advances made, only five percent of an estimated 7,000 rare diseases have an available treatment option. As life sciences companies begin to address the significant unmet need in the rare disease space, clinical-stage companies developing treatments for rare diseases face a number of challenges as they aim to bring products to market, particularly when on the global scale.

Medigus and Golden Grand Expand Distribution Arrangement in China for $27M of MUSE Systems

Tue, 18 Jul 2017 07:00:00 EDT

OMER, ISRAEL--(Marketwired - Jul 18, 2017) - Medigus Ltd. (NASDAQ: MDGS) (TASE: MDGS), a medical device company developing minimally invasive endosurgical tools and a leader in direct visualization technology, today announced that the Chinese exclusive distribution agreement with Golden Grand (Shanghai Golden Grand-Medical Instruments Ltd.) has been expanded to account for the increased interest in Medigus Ultrasonic Surgical Endostapler (MUSET) systems in China.

Remedy Health Media, LLC, Names Crenshaw Communications as PR Agency of Record

Mon, 17 Jul 2017 09:56:19 EDT

NEW YORK, NY--(Marketwired - Jul 17, 2017) - Crenshaw Communications, a New York-based public relations and content agency focused on digital technology brands, has been appointed by Remedy Health Media. Remedy Health Media is a leading digital health platform that provides content, tools, and real-life stories to patients and healthcare providers. Adds Major Healthcare System to Growing Roster of Virtual Care Customers

Mon, 17 Jul 2017 09:00:00 EDT

Adventist Health signs on to use SmartExam(TM) virtual patient visit tool, making primary care visits more productive

National Opioid Addiction Treatment Leader Launches Center in Glendale

Mon, 17 Jul 2017 09:00:00 EDT

CleanSlate Opens First of Several Centers in Wisconsin, Commits to Working with All Insurers so that Treatment is Available to All in Need Closes $8 Million Series B Round

Mon, 17 Jul 2017 09:00:00 EDT

Funding to Support Growth of SmartExam(TM) Software Firm that Already Boasts Healthcare Delivery Clients Nationwide

NEMUS Bioscience Announces NB2222 Pain and Anti-Addiction Data Accepted for Presentation at Upcoming Society of Neuroscience Meeting

Mon, 17 Jul 2017 08:30:00 EDT

COSTA MESA, CA--(Marketwired - Jul 17, 2017) - NEMUS Bioscience, Inc. (OTCQB: NMUS) announced that data recently obtained from the company's research and development partner, the University of Mississippi (UM), was accepted for presentation at the 2017 Annual Meeting of the Society of Neuroscience held in Washington, D.C. on November 11th-15th. The data being presented will show the superiority of the NEMUS proprietary analogue of CBD, NB2222, versus plant-derived CBD in ameliorating pain in a validated mouse (murine) model of chemotherapy-induced peripheral neuropathy using an opioid as an active comparator. Additional data will also be presented detailing the anti-addictive potential of NB2222 in an animal model of opioid addiction. The in vivo research was led by Professor Kenneth Sufka of the University of Mississippi based on the molecular cannabinoid discovery work performed by the team at ElSohly Laboratories, Inc. (ELI) in collaboration with the University, spearheaded by Dr. Mahmoud ElSohly, who also holds a faculty appointment at the University.

Extendicare Announces July 2017 Dividend of C$0.04 per Share

Mon, 17 Jul 2017 08:00:00 EDT

MARKHAM, ON--(Marketwired - July 17, 2017) - Extendicare Inc. ("Extendicare" or the "Company") (TSX: EXE) announced that it has declared a cash dividend of C$0.04 per common share of the Company (the "Common Share") for the month of July 2017, which is payable on August 15, 2017 to shareholders of record at the close of business on July 31, 2017. This dividend is designated as an "eligible dividend" within the meaning of the Income Tax Act (Canada).

MTBC First Half 2017 Shareholder Update

Mon, 17 Jul 2017 07:30:00 EDT

SOMERSET, NJ--(Marketwired - Jul 17, 2017) - MTBC (NASDAQ: MTBC) (NASDAQ: MTBCP), a leading provider of proprietary, cloud-based healthcare IT solutions and services, issued a letter to shareholders today with an update on first half 2017 results.

How to Maximize Your Non-GLP Toxicology Studies: A Guide for Optimal Design and Methodology

Mon, 17 Jul 2017 07:30:00 EDT

In this new webinar hosted by Xtalks, the presenters will share both design and methodology guidance in Non-GLP Toxicology studies in translational models. The session will guide viewers in how to design the most optimal study to provide the greatest opportunity to generate robust, high-quality data, that gives maximum confidence to select new drug candidates and regulatory submissions.

MedX Health Corp. Announces Further Closing of Brokered Private Placement

Fri, 14 Jul 2017 18:00:00 EDT

MISSISSAUGA, ON--(Marketwired - July 14, 2017) -


Mega Bridge, Inc. Announces Name Change to HypGen, Inc. and New Strategic Direction

Fri, 14 Jul 2017 09:30:00 EDT

NEW YORK, NY--(Marketwired - Jul 14, 2017) - Mega Bridge, Inc. (OTCQB: MGBR) announced today that it is planning to change its name from Mega Bridge, Inc. to HypGen, Inc. ("HypGen") HypGen intends to focus its efforts on developing therapeutic treatment options for Parkinson's disease. To spearhead this new strategic direction, HypGen's shareholders have elected Dr. McCoy L. Moretz as the new Chief Executive Officer, Chief Financial Officer, Chief Medical Officer and Chairman of the Board of Directors. Richard Chang has also been appointed to the Board of Directors.

The Joint Commission Introduces Revised Pain Assessment and Management Standards, for Accredited Hospitals, to Include Use of Non-Pharmacologic Treatments and Strategies

Thu, 13 Jul 2017 13:55:10 EDT

The National Certification Commission for Acupuncture and Oriental Medicine (NCCAOM)(R) Stresses Importance of Including Nondrug Approaches Administered by Licensed Independent Practitioners for Pain Management